Both MedTech and pharmaceutical companies have relied on our analysis to make decisions on tapping into revenue pockets, entering new markets.
Our analysis involves extensive in-depth interviews with key stakeholders including physicians, purchasing managers, CEOs of hospitals and allied healthcare professionals. We also utilize our extensive industry network to gather insights from senior CXO-level industry professionals with deep experience in those markets.
Multi-billion Dollar pharmaceutical conglomerate looking to deepen presence in Europe
Situation
Client, a global player in oncology specialty pharmaceuticals, wanted to broaden its presence in Western Europe and to increase sales
Our approach
We mapped EU4+UK as priority markets and conducted deep dive into
Product volume trends
Pricing trends and analysis
Future outlook
Reimbursement overview
Channel analysis
Go-to-market strategies
Product pipeline
Competitive landscape
We recommended a clear strategy per country along with prioritization. Our recommendations included resource allocation, budgets required, sales to be expected and 5 years business plan per country, along with list of top 10 target accounts per country
Results
Client was successful in getting board approval for aggressive entry into Europe. In a span of two years following our engagement, client gained significant market share which led them to invest further by setting up a manufacturing facility in Germany to further grow their business in Europe
Quick Enquiry For
121/7E Avenue Franklin Roosevelt 1050 Brussels, Belgium
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
